Debenture Agreements in the Biotechnology Industry

82 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Debenture
Debenture Agreements
Q BioMed Inc.
Biotechnology
2021
Amendment to Non-Convertible Debenture, dated April 24, 2024, between the Company and Altos
Debenture Agreements
Blue Water Vaccines Inc.
2024
8% Convertible Debenture dated April 12, 2024, issued by us to Yi Hua Chen
Debenture Agreements
RITTER PHARMACEUTICALS INC
2024
Form of 8% Convertible Debenture to be issued by the Company to Alpha Capital Anstalt [Exhibit A to the Securities Purchase Agreement dated February 26, 2024]
Debenture Agreements
RITTER PHARMACEUTICALS INC
2024
Debenture, dated January 23, 2024
Debenture Agreements
Blue Water Vaccines Inc.
2024
8% Senior Convertible Debenture Due December 22, 2025
Debenture Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2022
Fifth Amendment to $10,000 8% Convertible Debenture, dated October 7, 2021
Debenture Agreements
Qrons Inc.
Biotechnology
2021
Fourth Amendment to $15,000 8% Convertible Debenture, dated October 7, 2021
Debenture Agreements
Qrons Inc.
Biotechnology
2021
The Convertible Debenture
Debenture Agreements
Q BioMed Inc.
Biotechnology
NY
2021
Form of Senior Convertible Debenture
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2021
Form of Senior Convertible Debenture
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2021
Form of Debenture
Debenture Agreements
Q BioMed Inc.
Biotechnology
2020
Form of Senior Convertible Debenture
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2020
7% Original Issue Discount Senior Convertible Debenture due August 3, 2021
Debenture Agreements
VACCINEX, INC.
Biotechnology
NY
2020
Form of 7% Original Issue Discount Senior Secured Convertible Debenture due August 3, 2021
Debenture Agreements
VACCINEX, INC.
Biotechnology
NY
2020
Form of 5% Original Issue Discount Senior Secured Convertible Debenture dated June 26, 2020
Debenture Agreements
GeoVax Labs, Inc.
Biotechnology
NY
2020
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $64,900 dated March 18, 2020
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
Form of Senior Convertible Debenture
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2020
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $56,600 dated January 18, 2020
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
Form of Debenture
Debenture Agreements
Q BioMed Inc.
Biotechnology
2019
Convertible Debenture of Bioxytran, Inc. to Peak One Opportunity Fund, L.P. in the Principal Amount of $120,000 dated October 22, 2019
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NV
2019
8% Convertible Debenture of Bioxytran, Inc. to Peak One Opportunity Fund, L.P. in the Principal Amount of $120,000 dated October 22, 2019
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NV
2019
Form of Debenture
Debenture Agreements
Q BioMed Inc.
Biotechnology
2019
Form of 10% OID Convertible Delayed Draw Debenture
Debenture Agreements
BIOVIE INC.
Biotechnology
NY
2019
The Convertible Debenture
Debenture Agreements
Q BioMed Inc.
Biotechnology
UT
2019
Form of Debenture, issued by the Company to the Bridge Investors
Debenture Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Form of Debenture, issued by the Company to PeakOne
Debenture Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Amendment to 8% Secured Debentures by and between the Company and Debenture Holders
Debenture Agreements
Chanticleer Holdings, Inc.
Biotechnology
2019
Second Amendment to the $10,000 8% Convertible Debenture, dated September 9, 2018
Debenture Agreements
Qrons Inc.
Biotechnology
2019
First Amendment to $15,000 8% Convertible Debenture, dated September 9, 2018
Debenture Agreements
Qrons Inc.
Biotechnology
2019
Form of 2018 6% Convertible Debenture Issued by Biotech Products Services And Research, Inc., a Nevada corporation
Debenture Agreements
Organicell Regenerative Medicine, Inc.
Biotechnology
2018
Form of Debenture
Debenture Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2018
Form of 10% Senior Convertible Debenture
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Form of Debenture
Debenture Agreements
Q BioMed Inc.
Biotechnology
2018
Form of 10% Senior Convertible Debenture
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Form of 10% Senior Convertible Debenture
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Form of Senior Convertible Debenture
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2018
Form of Convertible Debenture
Debenture Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2018
8% Convertible Debenture, dated September 27, 2017, between the Company and CubeSquare LLC
Debenture Agreements
Qrons Inc.
Biotechnology
FL
2018
First Amendment to 8% Convertible Debenture, dated September 28, 2017, between the Company and CubeSquare LLC
Debenture Agreements
Qrons Inc.
Biotechnology
2018